• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Does digestive enzymes help with GI disease? What the research does and doesn't show

Digestive enzyme supplements are searched for IBS, GERD, celiac disease and other GI conditions, but the trials are narrow: one dyspepsia trial of DigeZyme, a negative celiac lab study, and prescription enzyme therapy for a completely different, diagnosed pancreatic disease.

By Electric Tiger Editorial

The evidence doesn't support digestive enzyme supplements, including DigeZyme, as a treatment for a diagnosed GI disease — IBS, GERD, celiac disease, Crohn's, ulcerative colitis or diverticulitis. The trials that exist test narrow, specific situations, and the one place enzyme therapy is genuinely proven for a GI disease uses a completely different, prescription-strength product than anything sold over the counter.

What the evidence doesn't support

It doesn't support digestive enzyme supplements as something that treats IBS, GERD, Crohn's disease, ulcerative colitis or diverticulitis — we haven't found a controlled trial testing an enzyme blend against any of those diagnoses. It also doesn't support an over-the-counter blend like DigeZyme as a way to eat gluten safely with celiac disease. A supplement is not a substitute for medical management of a diagnosed digestive disease, and ongoing symptoms deserve a doctor's evaluation rather than self-treatment with an enzyme product.

What the trials found

The closest thing to a GI-disease trial of DigeZyme itself studied functional dyspepsia, a diagnosis of persistent upper-digestive discomfort with no identifiable structural cause. In a 2018 randomized, placebo-controlled trial, 40 adults with this diagnosis took DigeZyme (150 mg/day) or a placebo for 60 days, and the DigeZyme group scored significantly better on symptom questionnaires at every follow-up. The trial's authors are employees of DigeZyme's own manufacturer, and it's the only clinical trial on this specific blend — a single, industry-run result for one specific diagnosis, not a broad GI-disease literature.

For celiac disease, a 2015 lab study tested five commercially available digestive enzyme supplements (not DigeZyme by name, but the same general category of product) for their ability to break down the specific gluten fragments that trigger the immune reaction in celiac disease. All five left the immunogenic gluten fragments largely intact. A purified single enzyme, prolyl endopeptidase from Aspergillus niger (AN-PEP) — not an ingredient in DigeZyme or most commercial blends — fully degraded those same fragments at a much lower dose in the same lab conditions. A more recent human study of AN-PEP in celiac patients found high adherence to a gluten-free diet, but it only tested people who were already avoiding gluten, not people actually eating it, so it doesn't establish that AN-PEP lets someone with celiac disease safely eat gluten. Either way, this is a different single enzyme, tested separately from DigeZyme or comparable multi-enzyme blends.

Enzyme therapy is genuinely proven for one GI disease: exocrine pancreatic insufficiency, where the pancreas stops making enough of its own digestive enzymes, most often diagnosed alongside cystic fibrosis or chronic pancreatitis. That's treated with prescription-strength pancreatic enzyme replacement therapy (PERT), an FDA-regulated drug dosed in thousands of enzyme units per capsule — not an over-the-counter supplement dosed in milligrams, like DigeZyme. Even there, a 2020 Cochrane review of 14 trials (641 people with cystic fibrosis) found only limited, low-to-moderate-quality evidence comparing different prescription formulations against each other, and no long-term effectiveness data.

Study Population & design Dose / method Result
2018 RCT (DigeZyme) 40 adults with functional dyspepsia DigeZyme, 150 mg/day, 60 days Improved symptom scores vs. placebo; industry-run, one trial
2015 lab study Five OTC enzyme supplements, in-vitro Standard label doses vs. purified AN-PEP OTC blends left immunogenic gluten fragments intact; AN-PEP alone degraded them at a lower dose
2020 Cochrane review 641 people with cystic fibrosis, 14 trials Prescription pancreatic enzyme replacement therapy Limited, low-to-moderate-quality evidence between formulations; established use is a diagnosed pancreatic disease, not IBS or celiac

What we found no trial for

We haven't found a controlled trial testing digestive enzyme supplementation, including DigeZyme, in people with IBS, GERD, Crohn's disease, ulcerative colitis, diverticulitis, or small intestinal bacterial overgrowth (SIBO). That's a real gap, not a "trials are still pending" situation we can point to — it's the honest state of the published literature we've searched.

Questions people ask

Will digestive enzymes help with IBS?

We haven't found a trial testing digestive enzyme supplementation, including DigeZyme, specifically in people with IBS. If IBS is a diagnosis you have or suspect, that's a conversation for a doctor rather than something to self-treat with an enzyme supplement.

Can digestive enzymes help with GERD?

We haven't found a trial testing this. The one DigeZyme trial studied functional dyspepsia, which overlaps with but isn't the same diagnosis as GERD, and didn't report reflux symptoms as a separate measure.

Do digestive enzymes help with celiac disease?

The digestive enzyme supplements tested in a 2015 lab study did not adequately break down the gluten fragments that trigger celiac disease's immune reaction. A different, purified enzyme (AN-PEP) did in the same lab conditions, but it isn't in DigeZyme, and the human research on it so far doesn't show it lets someone safely eat gluten. Celiac disease is managed with a strict gluten-free diet, not an enzyme supplement.

Are digestive enzymes good for Crohn's disease or ulcerative colitis?

We haven't found a trial testing digestive enzyme supplementation in either condition. Both are autoimmune digestive diseases that need ongoing medical management; a supplement isn't a substitute for that.

Are digestive enzymes good for diverticulitis?

We haven't found a trial testing this. Diverticulitis is a diagnosed infection or inflammation that's treated medically, not with an enzyme supplement.

When to talk to a doctor

Persistent or worsening symptoms of any of these conditions — abdominal pain, diarrhea, reflux, bleeding, or unexplained weight loss — are worth raising with a doctor rather than addressing with a digestive-enzyme supplement, which is not a treatment for a diagnosed GI disease. See digestive enzymes: what the research does and doesn't show for the broader research picture, and who should not take digestive enzymes for diagnosed conditions that need a doctor's input before trying one.

Sources

  1. Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study Journal of medicinal food · 2018 · PMID 30156436A 2018 placebo-controlled trial found that adults with functional dyspepsia who took DigeZyme (150 mg/day) for 60 days scored significantly better on several symptom questionnaires than those given a placebo, with no reported product-related side effects; the trial was run and funded by DigeZyme's own maker.
  2. Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements PloS one · 2015 · PMID 26030273A 2015 lab study found that five commercially available digestive enzyme supplements did not adequately break down the specific gluten fragments that trigger celiac disease's immune reaction, while a different, purified enzyme (AN-PEP, not found in DigeZyme) did so effectively at a lower dose in the same lab conditions.
  3. Aspergillus niger prolyl endopeptidase in celiac disease World journal of gastroenterology · 2024 · PMID 38983964A 2024 commentary on AN-PEP research in celiac disease notes that the enzyme has only been studied in patients already avoiding gluten, not in people actually eating it, so it doesn't yet show that the enzyme lets someone with celiac disease safely eat gluten.
  4. Pancreatic enzyme replacement therapy for people with cystic fibrosis The Cochrane database of systematic reviews · 2020 · PMID 32761612A 2020 Cochrane review of 14 trials in people with cystic fibrosis found only limited, low-to-moderate-quality evidence comparing prescription pancreatic enzyme formulations, used to prevent malnutrition and weight loss from diagnosed pancreatic insufficiency — a different, prescription-strength product used for the opposite goal of weight-loss marketing.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.